GlassScriptPhysician profile
Todd Mangione
NPI 1689735631
$22,554.80
in general payments reported to CMS, 2019-2025
8 companies · $1,567 in 2025
The $1,567 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.70 · 2021: $38.88 · 2022: $78.68 · 2023: $28.61 · 2024: $21K · 2025: $1,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $19K · Travel and Lodging: $2,079 · Food and Beverage: $1,284 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $19,000.00 |
| Travel and Lodging | $2,079.15 |
| Food and Beverage | $1,283.65 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $22,072.38 | 2024-2025 | |
| Boston Scientific Corporation | $141.24 | 2024 | Spyglass Discover |
| Allergan, INC. | $98.82 | 2019-2022 | |
| Sanara Medtech INC. | $79.92 | 2024-2025 | Celleraterx, Celleraterx |
| Smith+Nephew, INC. | $67.50 | 2019-2024 | Stravix, Oasis Micro, Pico 14 |
| Davol INC. | $49.11 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $28.28 | 2025 | |
| Integra Lifesciences Corporation | $17.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Mangione listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.